• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叉头框转录因子 O 亚家族成员 3a(FOXO3a)通过一种涉及 MMP13(基质金属蛋白酶 13)的新途径,将血管平滑肌细胞凋亡、基质降解、动脉粥样硬化和血管重塑联系起来。

FOXO3a (Forkhead Transcription Factor O Subfamily Member 3a) Links Vascular Smooth Muscle Cell Apoptosis, Matrix Breakdown, Atherosclerosis, and Vascular Remodeling Through a Novel Pathway Involving MMP13 (Matrix Metalloproteinase 13).

机构信息

From the Division of Cardiovascular Medicine, Addenbrooke's Hospital (H.Y., A.F., K.F., N.F., M.B.) and Department of Biochemistry (T.L.), University of Cambridge, United Kingdom; and Institute of Medical Biology, Peking Union Medical College, Chinese Academy of Medical Sciences, Kunming, Yunnan Province, China (Z.Y.).

出版信息

Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):555-565. doi: 10.1161/ATVBAHA.117.310502. Epub 2018 Jan 11.

DOI:10.1161/ATVBAHA.117.310502
PMID:29326312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5828387/
Abstract

OBJECTIVE

Vascular smooth muscle cell (VSMC) apoptosis accelerates atherosclerosis and promotes breakdown of the extracellular matrix, but the mechanistic links between these 2 processes are unknown. The forkhead protein FOXO3a (forkhead transcription factor O subfamily member 3a) is activated in human atherosclerosis and induces a range of proapoptotic and other transcriptional targets. We, therefore, determined the mechanisms and consequences of FOXO3a activation in atherosclerosis and arterial remodeling after injury.

APPROACH AND RESULTS

Expression of a conditional FOXO3a allele (FOXO3aA3ER) potently induced VSMC apoptosis, expression and activation of MMP13 (matrix metalloproteinase 13), and downregulation of endogenous TIMPs (tissue inhibitors of MMPs). and were direct FOXO3a transcriptional targets in VSMCs. Activation of endogenous FOXO3a also induced MMP13, extracellular matrix degradation, and apoptosis, and MMP13-specific inhibitors and fibronectin reduced FOXO3a-mediated apoptosis. FOXO3a activation in mice with VSMC-restricted FOXO3aA3ER induced MMP13 expression and activity and medial VSMC apoptosis. FOXO3a activation in FOXO3aA3ER/ApoE (apolipoprotein E deficient) mice increased atherosclerosis, increased necrotic core and reduced fibrous cap areas, and induced features of medial degeneration. After carotid artery ligation, FOXO3a activation increased VSMC apoptosis, VSMC proliferation, and neointima formation, all of which were reduced by MMP13 inhibition.

CONCLUSIONS

FOXO3a activation induces VSMC apoptosis and extracellular matrix breakdown, in part, because of transcriptional activation of MMP13. FOXO3a activation promotes atherosclerosis and medial degeneration and increases neointima after injury that is partly dependent on MMP13. FOXO3a-induced MMP activation represents a direct mechanistic link between VSMC apoptosis and matrix breakdown in vascular disease.

摘要

目的

血管平滑肌细胞(VSMC)凋亡加速动脉粥样硬化并促进细胞外基质的分解,但这两个过程之间的机制联系尚不清楚。叉头蛋白 FOXO3a(叉头转录因子 O 亚家族成员 3a)在人类动脉粥样硬化中被激活,并诱导一系列促凋亡和其他转录靶标。因此,我们确定了 FOXO3a 在动脉粥样硬化和损伤后动脉重塑中的激活机制和后果。

方法和结果

条件性 FOXO3a 等位基因(FOXO3aA3ER)的表达强力诱导 VSMC 凋亡、MMP13(基质金属蛋白酶 13)的表达和激活以及内源性 TIMPs(基质金属蛋白酶抑制剂)的下调。 和 是 VSMCs 中 FOXO3a 的直接转录靶标。内源性 FOXO3a 的激活也诱导了 MMP13、细胞外基质降解和凋亡,而 MMP13 特异性抑制剂和纤维连接蛋白减少了 FOXO3a 介导的凋亡。FOXO3a 在 VSMC 特异性 FOXO3aA3ER 小鼠中的激活诱导了 MMP13 的表达和活性以及中膜 VSMC 的凋亡。FOXO3a 在 FOXO3aA3ER/ApoE(载脂蛋白 E 缺乏)小鼠中的激活增加了动脉粥样硬化,增加了坏死核心和减少了纤维帽区域,并诱导了中膜退化的特征。在颈动脉结扎后,FOXO3a 的激活增加了 VSMC 凋亡、VSMC 增殖和新生内膜形成,所有这些都可以通过 MMP13 抑制来减少。

结论

FOXO3a 的激活诱导 VSMC 凋亡和细胞外基质降解,部分原因是 MMP13 的转录激活。FOXO3a 的激活促进了动脉粥样硬化和中膜退化,并增加了损伤后的新生内膜形成,这在一定程度上依赖于 MMP13。FOXO3a 诱导的 MMP 激活代表了血管疾病中 VSMC 凋亡和基质分解之间的直接机制联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/939ced196837/atv-38-555-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/a907f8381d5b/atv-38-555-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/cfefe99ec567/atv-38-555-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/cabb767216e3/atv-38-555-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/2a59a16594d6/atv-38-555-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/939ced196837/atv-38-555-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/a907f8381d5b/atv-38-555-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/cfefe99ec567/atv-38-555-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/cabb767216e3/atv-38-555-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/2a59a16594d6/atv-38-555-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6967/5828387/939ced196837/atv-38-555-g006.jpg

相似文献

1
FOXO3a (Forkhead Transcription Factor O Subfamily Member 3a) Links Vascular Smooth Muscle Cell Apoptosis, Matrix Breakdown, Atherosclerosis, and Vascular Remodeling Through a Novel Pathway Involving MMP13 (Matrix Metalloproteinase 13).叉头框转录因子 O 亚家族成员 3a(FOXO3a)通过一种涉及 MMP13(基质金属蛋白酶 13)的新途径,将血管平滑肌细胞凋亡、基质降解、动脉粥样硬化和血管重塑联系起来。
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):555-565. doi: 10.1161/ATVBAHA.117.310502. Epub 2018 Jan 11.
2
Akt1 regulates vascular smooth muscle cell apoptosis through FoxO3a and Apaf1 and protects against arterial remodeling and atherosclerosis.Akt1通过FoxO3a和凋亡蛋白酶激活因子1调节血管平滑肌细胞凋亡,并预防动脉重塑和动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2421-8. doi: 10.1161/ATVBAHA.114.304284. Epub 2014 Sep 18.
3
Membrane-Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions.血管平滑肌细胞表达的膜锚定金属蛋白酶限制增殖性动脉粥样硬化病变的进展。
J Am Heart Assoc. 2017 Jul 22;6(7):e003693. doi: 10.1161/JAHA.116.003693.
4
Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.可溶性环氧化物水解酶通过调节平滑肌细胞迁移参与动脉粥样硬化的发展和动脉内膜形成。
Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1894-903. doi: 10.1152/ajpheart.00289.2015. Epub 2015 Oct 9.
5
Matrix metalloproteinase-8 promotes vascular smooth muscle cell proliferation and neointima formation.基质金属蛋白酶-8 促进血管平滑肌细胞增殖和新生内膜形成。
Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):90-8. doi: 10.1161/ATVBAHA.113.301418. Epub 2013 Oct 24.
6
Loss of Smooth Muscle Tenascin-X Inhibits Vascular Remodeling Through Increased TGF-β Signaling.平滑肌腱蛋白 X 的缺失通过增加 TGF-β 信号抑制血管重塑。
Arterioscler Thromb Vasc Biol. 2024 Aug;44(8):1748-1763. doi: 10.1161/ATVBAHA.123.321067. Epub 2024 Jun 27.
7
Attenuated Superoxide Dismutase 2 Activity Induces Atherosclerotic Plaque Instability During Aging in Hyperlipidemic Mice.衰减弱化的超氧化物歧化酶 2 活性在高脂血症小鼠衰老过程中诱导动脉粥样硬化斑块不稳定。
J Am Heart Assoc. 2017 Oct 27;6(11):e006775. doi: 10.1161/JAHA.117.006775.
8
Insulin receptors in vascular smooth muscle cells regulate plaque stability of atherosclerosis.血管平滑肌细胞中的胰岛素受体调节动脉粥样硬化斑块的稳定性。
Cardiovasc Res. 2024 Dec 14;120(16):2017-2030. doi: 10.1093/cvr/cvae193.
9
Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.中介素通过 cAMP/PKA 通路调节血管平滑肌细胞表型减少新生内膜形成。
Atherosclerosis. 2017 Nov;266:212-222. doi: 10.1016/j.atherosclerosis.2017.10.011. Epub 2017 Oct 9.
10
Mixed-lineage kinase 3 deficiency promotes neointima formation through increased activation of the RhoA pathway in vascular smooth muscle cells.混合谱系激酶 3 缺乏通过增加血管平滑肌细胞中 RhoA 通路的激活促进新生内膜形成。
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1429-36. doi: 10.1161/ATVBAHA.114.303439. Epub 2014 May 1.

引用本文的文献

1
Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis.血管平滑肌细胞:动脉粥样硬化的治疗靶点
Rev Cardiovasc Med. 2025 Jun 26;26(6):28240. doi: 10.31083/RCM28240. eCollection 2025 Jun.
2
The Roles of Forkhead Box O3a (FOXO3a) in Bone and Cartilage Diseases - A Narrative Review.叉头框O3a(FOXO3a)在骨与软骨疾病中的作用——一篇叙述性综述
Drug Des Devel Ther. 2025 Feb 27;19:1357-1375. doi: 10.2147/DDDT.S494841. eCollection 2025.
3
Colchicine reduces neointima formation and VSMC phenotype transition by modulating SRF-MYOCD activation and autophagy.

本文引用的文献

1
KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.KLF4 依赖的平滑肌细胞表型调节在动脉粥样硬化斑块发病机制中起关键作用。
Nat Med. 2015 Jun;21(6):628-37. doi: 10.1038/nm.3866. Epub 2015 May 18.
2
Akt isoforms in vascular disease.血管疾病中的Akt亚型
Vascul Pharmacol. 2015 Aug;71:57-64. doi: 10.1016/j.vph.2015.03.003. Epub 2015 Apr 28.
3
Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.遗传证据支持Akt1在动脉粥样硬化形成过程中对血管平滑肌细胞起主要作用。
秋水仙碱通过调节血清反应因子-肌细胞增强因子2D(SRF-MYOCD)的激活和自噬来减少新生内膜形成和平滑肌细胞(VSMC)表型转变。
Acta Pharmacol Sin. 2025 Apr;46(4):951-963. doi: 10.1038/s41401-024-01438-x. Epub 2024 Dec 11.
4
An update on ox-LDL-inducing vascular smooth muscle cell-derived foam cells in atherosclerosis.氧化低密度脂蛋白诱导动脉粥样硬化中血管平滑肌细胞源性泡沫细胞的研究进展
Front Cell Dev Biol. 2024 Oct 25;12:1481505. doi: 10.3389/fcell.2024.1481505. eCollection 2024.
5
FOXO3 Longevity Genotype Mitigates Risk Posed by Hypertension on Incident Coronary Artery Disease in Middle-Aged Men: Kuakini Honolulu Heart Program.FOXO3长寿基因型减轻中年男性高血压对冠心病发病风险的影响:库阿基尼檀香山心脏项目
J Gerontol A Biol Sci Med Sci. 2024 Dec 1;79(12). doi: 10.1093/gerona/glae254.
6
Yohimbine Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation and Migration via FOXO3a Factor.育亨宾通过 FOXO3a 因子抑制 PDGF 诱导的血管平滑肌细胞增殖和迁移。
Int J Mol Sci. 2024 Jun 24;25(13):6899. doi: 10.3390/ijms25136899.
7
Involvement of Kindlin-1 in cutaneous squamous cell carcinoma.黏着斑蛋白-1在皮肤鳞状细胞癌中的作用
Oncogenesis. 2024 Jul 9;13(1):24. doi: 10.1038/s41389-024-00526-1.
8
Oxidative DNA damage promotes vascular ageing associated with changes in extracellular matrix-regulating proteins.氧化性DNA损伤会促进与细胞外基质调节蛋白变化相关的血管衰老。
Cardiovasc Res. 2025 May 6;121(4):614-628. doi: 10.1093/cvr/cvae091.
9
Increased Oxidative Stress and Decreased Sirtuin-3 and FOXO3 Expression Following Carotid Artery Intimal Injury in Hyperlipidemic Yucatan Microswine.高脂血症尤卡坦小型猪颈动脉内膜损伤后氧化应激增加及沉默调节蛋白3和FOXO3表达降低
Cardiol Cardiovasc Med. 2024;8(1):33-42. doi: 10.26502/fccm.92920355. Epub 2024 Jan 22.
10
FoxO3 normalizes Smad3-induced arterial smooth muscle cell growth.FoxO3使Smad3诱导的动脉平滑肌细胞生长正常化。
Front Physiol. 2023 Aug 24;14:1136998. doi: 10.3389/fphys.2023.1136998. eCollection 2023.
Circ Res. 2015 May 22;116(11):1744-52. doi: 10.1161/CIRCRESAHA.116.305895. Epub 2015 Apr 13.
4
Previously differentiated medial vascular smooth muscle cells contribute to neointima formation following vascular injury.先前分化的血管内侧平滑肌细胞在血管损伤后有助于新生内膜的形成。
Vasc Cell. 2014 Oct 1;6:21. doi: 10.1186/2045-824X-6-21. eCollection 2014.
5
Akt1 regulates vascular smooth muscle cell apoptosis through FoxO3a and Apaf1 and protects against arterial remodeling and atherosclerosis.Akt1通过FoxO3a和凋亡蛋白酶激活因子1调节血管平滑肌细胞凋亡,并预防动脉重塑和动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2421-8. doi: 10.1161/ATVBAHA.114.304284. Epub 2014 Sep 18.
6
Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis.血管平滑肌细胞中的沉默调节蛋白 1 可抵抗 DNA 损伤并抑制动脉粥样硬化。
Circulation. 2013 Jan 22;127(3):386-96. doi: 10.1161/CIRCULATIONAHA.112.124404. Epub 2012 Dec 7.
7
FOXOs and sirtuins in vascular growth, maintenance, and aging.FOXOs 和 Sirtuins 在血管生长、维持和衰老中的作用。
Circ Res. 2012 Apr 27;110(9):1238-51. doi: 10.1161/CIRCRESAHA.111.246488.
8
Matrix metalloproteinase inhibition therapy for vascular diseases.基质金属蛋白酶抑制治疗血管疾病。
Vascul Pharmacol. 2012 May-Jun;56(5-6):232-44. doi: 10.1016/j.vph.2012.01.007. Epub 2012 Feb 1.
9
NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II.尿皮质素-Ⅱ通过 NOX4 介导 FoxO3a 和基质金属蛋白酶-2 表达的激活。
Mol Biol Cell. 2011 Nov;22(22):4424-34. doi: 10.1091/mbc.E10-12-0971. Epub 2011 Sep 30.
10
Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis.选择性抑制基质金属蛋白酶-13 可增加已建立的小鼠动脉粥样硬化中的胶原含量。
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2464-72. doi: 10.1161/ATVBAHA.111.231563.